Biopharmx Corp Stock Nyse
Equities
US09072X1019
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 887K | Sales 2022 | 83.18K | Capitalization | 5.2M |
---|---|---|---|---|---|
Net income 2021 | -10M | Net income 2022 | -19M | EV / Sales 2021 | 11.5 x |
Net cash position 2021 | 14.05M | Net cash position 2022 | 8.75M | EV / Sales 2022 | -42.7 x |
P/E ratio 2021 |
-1.43
x | P/E ratio 2022 |
-0.19
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |